These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 14675241)

  • 41. Screening for colorectal cancer: what is the most cost-effective approach?
    Bolin TD; Lapsley HM; Korman MG
    Med J Aust; 2001 Mar; 174(6):298-301. PubMed ID: 11297120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.
    Vanness DJ; Knudsen AB; Lansdorp-Vogelaar I; Rutter CM; Gareen IF; Herman BA; Kuntz KM; Zauber AG; van Ballegooijen M; Feuer EJ; Chen MH; Johnson CD
    Radiology; 2011 Nov; 261(2):487-98. PubMed ID: 21813740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.
    Song K; Fendrick AM; Ladabaum U
    Gastroenterology; 2004 May; 126(5):1270-9. PubMed ID: 15131787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of screening the average-risk population for colorectal cancer.
    Provenzale D
    Gastrointest Endosc Clin N Am; 2002 Jan; 12(1):93-109. PubMed ID: 11916165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model.
    Rodríguez-Moranta F; Trapero-Bertran M; Castells A; Mas-Canal X; Balaguer F; Pellisé M; Gonzalo V; Ocaña T; Trilla A; Piqué JM
    Gastroenterol Hepatol; 2008; 31(7):405-12. PubMed ID: 18783684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
    El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
    Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness of patient mailings to promote colorectal cancer screening.
    Sequist TD; Franz C; Ayanian JZ
    Med Care; 2010 Jun; 48(6):553-7. PubMed ID: 20473196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 50. Cost Effectiveness of Screening Colonoscopy Depends on Adequate Bowel Preparation Rates - A Modeling Study.
    Kingsley J; Karanth S; Revere FL; Agrawal D
    PLoS One; 2016; 11(12):e0167452. PubMed ID: 27936028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis.
    van Rossum LG; van Rijn AF; Verbeek AL; van Oijen MG; Laheij RJ; Fockens P; Jansen JB; Adang EM; Dekker E
    Int J Cancer; 2011 Apr; 128(8):1908-17. PubMed ID: 20589677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
    Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of workup strategy on the cost-effectiveness of fecal occult blood screening for colorectal cancer.
    Barry MJ; Mulley AG; Richter JM
    Gastroenterology; 1987 Aug; 93(2):301-10. PubMed ID: 3109993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized controlled trial: Flexible sigmoidoscopy as an adjunct to faecal occult blood testing in population screening.
    Steele RJ; Carey FA; Stanners G; Lang J; Brand J; Brownlee LA; Crichton EM; Winter JW; Phull PS; Mowat C; Strachan JA; Digan AM; Fraser CG
    J Med Screen; 2020 Jun; 27(2):59-67. PubMed ID: 31690179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Individual screening for colorectal cancer: which strategy for which patient?].
    Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A
    Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fecal occult blood testing for colorectal cancer. Can we afford not to do this?
    Bond JH
    Gastroenterol Clin North Am; 1997 Mar; 26(1):57-70. PubMed ID: 9119440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening strategies for colorectal cancer: a systematic review of the evidence.
    McLeod RS;
    Can J Gastroenterol; 2001 Oct; 15(10):647-60. PubMed ID: 11694901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost benefit of early diagnosis of colorectal cancer.
    Bolin TD
    Scand J Gastroenterol Suppl; 1996; 220():142-6. PubMed ID: 8898453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flexible sigmoidoscopy versus fecal occult blood testing for colorectal cancer screening in asymptomatic individuals.
    Stern C
    Clin J Oncol Nurs; 2014 Aug; 18(4):471-2. PubMed ID: 25095304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.